Inhibition of Apoptosis and NF-kappa B Activation by Vaccinia Protein N1 Occur via Distinct Binding Surfaces and Make Different Contributions to Virulence

Vaccinia virus (VACV) protein N1 is an intracellular virulence factor and belongs to a family of VACV B-cell lymphoma (Bcl)-2-like proteins whose members inhibit apoptosis or activation of pro-inflammatory transcription factors, such as interferon (IFN) regulatory factor-3 (IRF-3) and nuclear factor...

Full description

Bibliographic Details
Main Authors: de Motes, C, Cooray, S, Ren, H, Almeida, G, McGourty, K, Bahar, M, Stuart, D, Grimes, J, Graham, S, Smith, G
Format: Journal article
Published: 2011
_version_ 1797061180503621632
author de Motes, C
Cooray, S
Ren, H
Almeida, G
McGourty, K
Bahar, M
Stuart, D
Grimes, J
Graham, S
Smith, G
author_facet de Motes, C
Cooray, S
Ren, H
Almeida, G
McGourty, K
Bahar, M
Stuart, D
Grimes, J
Graham, S
Smith, G
author_sort de Motes, C
collection OXFORD
description Vaccinia virus (VACV) protein N1 is an intracellular virulence factor and belongs to a family of VACV B-cell lymphoma (Bcl)-2-like proteins whose members inhibit apoptosis or activation of pro-inflammatory transcription factors, such as interferon (IFN) regulatory factor-3 (IRF-3) and nuclear factor-κB (NF-κB). Unusually, N1 inhibits both apoptosis and NF-κB activation. To understand how N1 exerts these different functions, we have mutated residues in the Bcl-2-like surface groove and at the interface used to form N1 homodimers. Mutagenesis of the surface groove abolished only the N1 anti-apoptotic activity and protein crystallography showed these mutants differed from wild-type N1 only at the site of mutation. Conversely, mutagenesis of the dimer interface converted N1 to a monomer and affected only inhibition of NF-κB activation. Collectively, these data show that N1 inhibits pro-inflammatory and pro-apoptotic signalling using independent surfaces of the protein. To determine the relative contribution of each activity to virus virulence, mutant N1 alleles were introduced into a VACV strain lacking N1 and the virulence of these viruses was analysed after intradermal and intranasal inoculation in mice. In both models, VACV containing a mutant N1 unable to inhibit apoptosis had similar virulence to wild-type virus, whereas VACV containing a mutant N1 impaired for NF-κB inhibition induced an attenuated infection similar to that of the N1-deleted virus. This indicates that anti-apoptotic activity of N1 does not drive virulence in these in vivo models, and highlights the importance of pro-inflammatory signalling in the immune response against viral infections.
first_indexed 2024-03-06T20:27:22Z
format Journal article
id oxford-uuid:2fd7c7bd-6d80-414f-91cc-ac920047b011
institution University of Oxford
last_indexed 2024-03-06T20:27:22Z
publishDate 2011
record_format dspace
spelling oxford-uuid:2fd7c7bd-6d80-414f-91cc-ac920047b0112022-03-26T12:57:56ZInhibition of Apoptosis and NF-kappa B Activation by Vaccinia Protein N1 Occur via Distinct Binding Surfaces and Make Different Contributions to VirulenceJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:2fd7c7bd-6d80-414f-91cc-ac920047b011Symplectic Elements at Oxford2011de Motes, CCooray, SRen, HAlmeida, GMcGourty, KBahar, MStuart, DGrimes, JGraham, SSmith, GVaccinia virus (VACV) protein N1 is an intracellular virulence factor and belongs to a family of VACV B-cell lymphoma (Bcl)-2-like proteins whose members inhibit apoptosis or activation of pro-inflammatory transcription factors, such as interferon (IFN) regulatory factor-3 (IRF-3) and nuclear factor-κB (NF-κB). Unusually, N1 inhibits both apoptosis and NF-κB activation. To understand how N1 exerts these different functions, we have mutated residues in the Bcl-2-like surface groove and at the interface used to form N1 homodimers. Mutagenesis of the surface groove abolished only the N1 anti-apoptotic activity and protein crystallography showed these mutants differed from wild-type N1 only at the site of mutation. Conversely, mutagenesis of the dimer interface converted N1 to a monomer and affected only inhibition of NF-κB activation. Collectively, these data show that N1 inhibits pro-inflammatory and pro-apoptotic signalling using independent surfaces of the protein. To determine the relative contribution of each activity to virus virulence, mutant N1 alleles were introduced into a VACV strain lacking N1 and the virulence of these viruses was analysed after intradermal and intranasal inoculation in mice. In both models, VACV containing a mutant N1 unable to inhibit apoptosis had similar virulence to wild-type virus, whereas VACV containing a mutant N1 impaired for NF-κB inhibition induced an attenuated infection similar to that of the N1-deleted virus. This indicates that anti-apoptotic activity of N1 does not drive virulence in these in vivo models, and highlights the importance of pro-inflammatory signalling in the immune response against viral infections.
spellingShingle de Motes, C
Cooray, S
Ren, H
Almeida, G
McGourty, K
Bahar, M
Stuart, D
Grimes, J
Graham, S
Smith, G
Inhibition of Apoptosis and NF-kappa B Activation by Vaccinia Protein N1 Occur via Distinct Binding Surfaces and Make Different Contributions to Virulence
title Inhibition of Apoptosis and NF-kappa B Activation by Vaccinia Protein N1 Occur via Distinct Binding Surfaces and Make Different Contributions to Virulence
title_full Inhibition of Apoptosis and NF-kappa B Activation by Vaccinia Protein N1 Occur via Distinct Binding Surfaces and Make Different Contributions to Virulence
title_fullStr Inhibition of Apoptosis and NF-kappa B Activation by Vaccinia Protein N1 Occur via Distinct Binding Surfaces and Make Different Contributions to Virulence
title_full_unstemmed Inhibition of Apoptosis and NF-kappa B Activation by Vaccinia Protein N1 Occur via Distinct Binding Surfaces and Make Different Contributions to Virulence
title_short Inhibition of Apoptosis and NF-kappa B Activation by Vaccinia Protein N1 Occur via Distinct Binding Surfaces and Make Different Contributions to Virulence
title_sort inhibition of apoptosis and nf kappa b activation by vaccinia protein n1 occur via distinct binding surfaces and make different contributions to virulence
work_keys_str_mv AT demotesc inhibitionofapoptosisandnfkappabactivationbyvacciniaproteinn1occurviadistinctbindingsurfacesandmakedifferentcontributionstovirulence
AT coorays inhibitionofapoptosisandnfkappabactivationbyvacciniaproteinn1occurviadistinctbindingsurfacesandmakedifferentcontributionstovirulence
AT renh inhibitionofapoptosisandnfkappabactivationbyvacciniaproteinn1occurviadistinctbindingsurfacesandmakedifferentcontributionstovirulence
AT almeidag inhibitionofapoptosisandnfkappabactivationbyvacciniaproteinn1occurviadistinctbindingsurfacesandmakedifferentcontributionstovirulence
AT mcgourtyk inhibitionofapoptosisandnfkappabactivationbyvacciniaproteinn1occurviadistinctbindingsurfacesandmakedifferentcontributionstovirulence
AT baharm inhibitionofapoptosisandnfkappabactivationbyvacciniaproteinn1occurviadistinctbindingsurfacesandmakedifferentcontributionstovirulence
AT stuartd inhibitionofapoptosisandnfkappabactivationbyvacciniaproteinn1occurviadistinctbindingsurfacesandmakedifferentcontributionstovirulence
AT grimesj inhibitionofapoptosisandnfkappabactivationbyvacciniaproteinn1occurviadistinctbindingsurfacesandmakedifferentcontributionstovirulence
AT grahams inhibitionofapoptosisandnfkappabactivationbyvacciniaproteinn1occurviadistinctbindingsurfacesandmakedifferentcontributionstovirulence
AT smithg inhibitionofapoptosisandnfkappabactivationbyvacciniaproteinn1occurviadistinctbindingsurfacesandmakedifferentcontributionstovirulence